SCHEMBL16305676

SCHEMBL16305676

CCCCCCCOc1ccc(-c2cnc(-c3ccc(C[C@H](NC(=O)c4ccc(C(C)(C)C)cc4)C(=O)N4CCC4C(=O)O)cc3)nc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 3/20 0.42
▸ PPARA Q07869 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ACE P12821 6/20 0.41
▸ HRH2 P25021 3/20 0.41
▸ HRH1 P35367 3/20 0.41
▸ ITGB1 P05556 2/20 0.41
▸ ITGA4 P13612 2/20 0.41
▸ ITGB3 P05106 2/20 0.40
▸ ITGA2B P08514 2/20 0.40
▸ PLG P00747 1/20 0.40
▸ ACE2 Q9BYF1 5/20 0.40
▸ S1PR5 Q9H228 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16305979 0.96 L3MBTL1 (0.48) L3MBTL1ACEACE2
SCHEMBL20426117 0.96 L3MBTL1 (0.48) L3MBTL1ACEACE2
SCHEMBL17834426 0.90 L3MBTL1 (0.47) L3MBTL1ACEACE2
SCHEMBL19485713 0.90 L3MBTL1 (0.51) L3MBTL1ACEACE2
SCHEMBL16305672 0.89 ACE (0.42) PPARGPPARAACEHRH2HRH1
SCHEMBL16305673 0.89 ACE (0.42) PPARGPPARAACEHRH2HRH1
SCHEMBL16305678 0.89 ACE (0.42) PPARGPPARAACEHRH2HRH1
SCHEMBL16305664 0.89 ACE (0.42) PPARGPPARAACEHRH2HRH1
SCHEMBL16306051 0.89 S1PR5 (0.47) PPARGPPARAHRH2HRH1ITGB1
SCHEMBL16305381 0.89 ITGB1 (0.39) L3MBTL1ACEHRH2HRH1ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008056-B1 NOVEL GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-12-09 — — EP disclosed
EP-3230276-B1 GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-09-02 — — EP disclosed
US-10259823-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2019-04-16 — — US disclosed
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2018-01-25 — — US disclosed
US-20170313717-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2017-11-02 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2016-08-11 — — US disclosed
US-20160214993-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2016-07-28 — — US disclosed
WO-2016094729-A1 GLP-1 RECEPTOR MODULATORS CELGENE INTERNATIONAL II SARL (CH) 2016-06-16 — — WO disclosed
US-20150011527-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2015-01-08 — — US disclosed
WO-2014201172-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS, INC. (US) 2014-12-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PPARG 317/4885PPARA 491/4885L3MBTL1 771/4885
US-20170313717-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PPARG 317/4885PPARA 491/4885L3MBTL1 771/4885
US-20160214993-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PPARG 317/4885PPARA 491/4885L3MBTL1 771/4885
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PPARG 317/4885PPARA 491/4885L3MBTL1 771/4885
US-10034886-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR PPARG 263/4885PPARA 417/4885L3MBTL1 579/4885
US-10259823-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR PPARG 263/4885PPARA 417/4885L3MBTL1 579/4885
US-20150011527-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R PPARG 317/4885PPARA 491/4885L3MBTL1 771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback